Models of the BBB was an online event with the following theme: "Scientific tools to target the brain", organised by the Faculty of Pharmacy, University of Lisbon (March 18-20, 2022). NOVIRUSES2BRAIN researchers, Miguel Castanho and Vera Neves from faculty of Medicine, University of Lisbon gave two scientific talks about "Drug conjugation as a tool to overcome the BBB" and "Peptides shuttles for receptor-independent ...
PhD Student, Daniel Gavino, from the Federal University of Rio de Janeiro (Brazil) has visited the Miguel Castanho Lab at Instituto de Medicina Molecular João Lobo Antunes (Lisboa, Portugal) to share his expertise in the animal model of Zika viral infection and to learn more about other biophysical techniques.
Professor Miguel Castanho, principal investigator at Instituto de Medicina Molecular João Lobo Antunes (Lisboa, Portugal), explains how these molecules can help when the virus settles in the brain (December 13, 2021). https://observador.pt/programas/e-mc2/vih-portugueses-criam-moleculas-que-ajudam-a-tratar-disturbios-neurocognitivos/ (in portuguese).
"Did you know that antibiotics are used in cleaning and food? Excessive use makes viruses resistant to treatments", explains Professor Miguel Castanho, principal investigator at Instituto de Medicina Molecular João Lobo Antunes (Lisboa, Portugal), during the E=mc² program on Observador Radio (November 30, 2021). https://observador.pt/programas/e-mc2/virus-mais-resistentes-a-culpa-e-dos-antibioticos/ (in Portuguese)
Two members of NOVIRUSES2BRAIN project attended to the 7th International Iberian Biophysics Congress which took place on 14-16 June 2021 in an online format. Professor Miguel Castanho gave a lecture on "Pursuing innovative peptide drugs with biophysical approaches: why, what, what for?" and the PhD student Diogo Mendonça gave a scientific talk ...
The 3rd Periodic Working Meeting included all the team members and took place by videoconference. The project has now a set of preliminary and promising results regarding the study of molecules efficacious against Zika, Dengue, HIV and SARS-CoV-2 viruses.